Insider Trading activities of Htg Molecular Diagnostics, Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Htg Molecular Diagnostics, Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Htg Molecular Diagnostics, Inc since year 2005. Table 2 shows the detailed insider transactions of Htg Molecular Diagnostics, Inc since 2005. The reporting company's ticker symbol is HTGM. The reporting company's CIK number is 1169987.
The total value of stock buying since 2005 is $14,128,425.
The total value of stock sales since 2005 is $5,461,544.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Htg Molecular Diagnostics, Inc (HTGM).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 0 $0 1,230,399 $2,252,880 0 $0
2017-03 0 $0 300,000 $3,045,300 0 $0
2016-04 0 $0 8,983 $25,983 0 $0
2016-03 0 $0 55,063 $137,381 0 $0
2015-08 19,150 $128,425 0 $0 0 $0
2015-05 1,000,000 $14,000,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Htg Molecular Diagnostics, Inc insiders (HTGM)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-25 Novo Holdings A/s (10% Owner) Sale 720,214 1.75 1,260,374
2017-08-24 Novo Holdings A/s (10% Owner) Sale 382,437 1.91 730,072
2017-08-23 Novo Holdings A/s (10% Owner) Sale 47,162 2.02 95,455
2017-08-22 Novo Holdings A/s (10% Owner) Sale 12,641 2.01 25,408
2017-08-21 Novo Holdings A/s (10% Owner) Sale 12,845 2.02 25,972
2017-08-18 Novo Holdings A/s (10% Owner) Sale 55,100 2.10 115,599
2017-03-27 Glaxosmithkline Plc Sale 300,000 10.15 3,045,300
2016-04-04 Lubniewski John L (Chief Business Officer) Sale 87 2.92 254
2016-04-04 Gordon Debra A (V.P. and Chief Legal Counsel) Sale 183 2.92 535
2016-04-04 Mcmeans Shaun D (VP, Finance & Admin. & CFO) Sale 175 2.92 511
2016-04-04 Johnson Tim B (President & CEO) Sale 538 2.92 1,573
2016-04-01 Lubniewski John L (Chief Business Officer) Sale 709 2.89 2,048
2016-04-01 Gordon Debra A (V.P. and Chief Legal Counsel) Sale 1,489 2.89 4,301
2016-04-01 Mcmeans Shaun D (VP, Finance & Admin. & CFO) Sale 1,426 2.89 4,119
2016-04-01 Johnson Tim B (President & CEO) Sale 4,376 2.89 12,642
2016-03-14 Lubniewski John L (Chief Business Officer) Sale 113 2.19 247
2016-03-14 Gordon Debra A (V.P. and Chief Legal Counsel) Sale 109 2.19 238
2016-03-14 Roche Patrick C. (SVP Research & Development) Sale 111 2.19 242
2016-03-14 Mcmeans Shaun D (VP, Finance & Admin. & CFO) Sale 109 2.19 238
2016-03-14 Johnson Tim B (President & CEO) Sale 125 2.19 273
2016-03-11 Lubniewski John L (Chief Business Officer) Sale 5,264 2.35 12,396
2016-03-11 Gordon Debra A (V.P. and Chief Legal Counsel) Sale 4,215 2.35 9,926
2016-03-11 Roche Patrick C. (SVP Research & Development) Sale 4,520 2.35 10,644
2016-03-11 Mcmeans Shaun D (VP, Finance & Admin. & CFO) Sale 4,305 2.35 10,138
2016-03-11 Johnson Tim B (President & CEO) Sale 8,154 2.35 19,202
2016-03-10 Lubniewski John L (Chief Business Officer) Sale 1,512 2.49 3,764
2016-03-10 Gordon Debra A (V.P. and Chief Legal Counsel) Sale 1,211 2.49 3,015
2016-03-10 Roche Patrick C. (SVP Research & Development) Sale 1,298 2.49 3,232
2016-03-10 Mcmeans Shaun D (VP, Finance & Admin. & CFO) Sale 1,237 2.49 3,080
2016-03-10 Johnson Tim B (President & CEO) Sale 2,342 2.49 5,831
2016-03-09 Lubniewski John L (Chief Business Officer) Sale 4,067 2.69 10,928
2016-03-09 Gordon Debra A (V.P. and Chief Legal Counsel) Sale 3,256 2.69 8,748
2016-03-09 Roche Patrick C. (SVP Research & Development) Sale 3,491 2.69 9,380
2016-03-09 Mcmeans Shaun D (VP, Finance & Admin. & CFO) Sale 3,325 2.69 8,934
2016-03-09 Johnson Tim B (President & CEO) Sale 6,299 2.69 16,925
2015-08-24 Gordon Debra A (V.P. and Chief Legal Counsel) Buy 1,000 5.16 5,160
2015-08-24 Johnson Tim B (President & CEO) Buy 1,000 5.34 5,341
2015-08-18 Roche Patrick C. (SVP Research & Development) Buy 6,500 5.81 37,784
2015-08-12 Mcmeans Shaun D (VP, Finance & Admin. & CFO) Buy 650 7.50 4,875
2015-08-12 Johnson Tim B (President & CEO) Buy 5,000 7.47 37,340
2015-08-11 Lubniewski John L (Chief Business Officer) Buy 5,000 7.58 37,925
2015-05-11 Senour Lawrence D. (10% Owner) Buy 167,343 14.00 2,342,802
2015-05-11 Fsv Ii-b Lp (10% Owner) Buy 102,445 14.00 1,434,230
2015-05-11 Novo A/s (10% Owner) Buy 365,106 14.00 5,111,484
2015-05-11 Glaxosmithkline Plc Buy 365,106 14.00 5,111,484

Insider trading activities including stock purchases, stock sales, and option exercises of HTGM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Htg Molecular Diagnostics, Inc (symbol HTGM, CIK number 1169987) see the Securities and Exchange Commission (SEC) website.